{
    "eid": "2-s2.0-85078878431",
    "title": "C-myc contributes to malignancy of lung cancer: A potential anticancer drug target",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Anticancer drug target",
        "C-Myc",
        "Lung cancer",
        "Proto-oncogene",
        "Review"
    ],
    "authors": [
        "Pithi Chanvorachote",
        "Nicharat Sriratanasak",
        "Nongyao Nonpanya"
    ],
    "citedby-count": 47,
    "ref-count": 101,
    "ref-list": [
        "DNA damage, mutagenesis and cancer",
        "Deregulation of cell signaling in cancer",
        "Broad targeting of resistance to apoptosis in cancer",
        "Tumor mechanisms of resistanceto immune attack",
        "Cancer stem cells: Emergent nature of tumor emergency",
        "Family matters: How MYC family oncogenes impact small cell lung cancer",
        "The proto-oncogene c-myc and apoptosis",
        "MYC deregulation in primary human cancers",
        "Emerging roles of C-myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: A potential therapeutic target against colorectal cancer",
        "C-MYC: More than just a matter of life and death",
        "MYC on the path to cancer",
        "Cancer statistics, 2019",
        "Cancer stem cells: Role in tumor progression and treatment resistance",
        "Normal stem cells and cancer stem cells: The niche matters",
        "Strategies to inhibit Myc and their clinical applicability",
        "The Myc oncoprotein as a therapeutic target for human cancer",
        "Apoptosis and cancer a genesis of a research field",
        "C-Myc enhances protein synthesis and cell size during B lymphocyte development",
        "C-myc overexpression and p53 loss cooperate to promote genomic instability",
        "C-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression",
        "Defective double-strand DNA break repair and chromosomal translocations by MYC overexpression",
        "Attacking c-Myc: Targeted and combined therapies for cancer",
        "MYC, metabolism, and cancer",
        "Apoptosis triggered by Myc-Induced suppression of Bcl-XL or Bcl-2 is bypassed during lymphomagenesis",
        "Targeting oncogenic Myc as a strategy for cancer treatment",
        "Myc proteins as therapeutic targets",
        "Therapeutic inhibition of myc in cancer. Structural bases and computeraided drug discovery approaches",
        "Reversible tumorigenesis by MYC in hematopoietic lineages",
        "C-myc amplification in breast cancer: A meta-analysis of its occurrence and prognostic relevance",
        "Immunohistochemistry of c-myc expression in breast carcinoma",
        "C-myc oncogene product expression and prognosis in operable breast cancer",
        "CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis",
        "Association of nuclear PIM1 expression with lymph node metastasis and poor prognosis in patients with lung adenocarcinoma and squamous cell carcinoma",
        "Aberrant Wntl beta-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery",
        "Association between Vitamin D deficiencies in sarcoidosis with disease activity, course of disease and stages of lung involvements",
        "Association of overexpressed MYC gene with altered PHACTR3 and E2F4 genes contributes to nonsmall cell lung carcinoma pathogenesis",
        "Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines",
        "Myc oncogenes and human neoplastic disease",
        "Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model",
        "C-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia",
        "MYC and breast cancer",
        "Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide",
        "Cisplatin resistance and transcription factors",
        "The dual roles of MYC in genomic instability and cancer chemoresistance",
        "Drug resistance mechanisms in non-small cell lung carcinoma",
        "Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors",
        "The role of EGFR tyrosine kinase inhibitors in the first-line treatment of advanced non small cell lung cancer patients harboring EGFR mutation",
        "Novel chemotherapy regimens for advanced lung cancer: Have we reached a plateau?",
        "Cisplatin in cancer therapy: Molecular mechanisms of action",
        "Drug resistance and its significance for treatment decisions in non-small-cell lung cancer",
        "Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc",
        "Cisplatin (cis-diamminedichloroplatinum II)",
        "Resistance to cis- And carboplatin initiated by epigenetic changes in ovarian cancer patients",
        "The Bcl-2 apoptotic switch in cancer development and therapy",
        "Elevated apoptosis impairs epithelial cell turnover and shortens villi in TNF-driven intestinal inflammation",
        "Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPVnegative head and neck squamous cell carcinoma",
        "Epithelial mesenchymal transition in tumor metastasis",
        "Epithelial to mesenchymal plasticity: Role in cancer progression",
        "Molecular mechanisms of epithelial-mesenchymal transition",
        "Crosstalk of oncogenic signaling pathways during epithelial mesenchymal transition",
        "The role of EMT and MET in cancer dissemination",
        "MYC and metastasis",
        "Relationship of c-Myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis",
        "Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells",
        "Conversion of stem cells to cancer stem cells: Undercurrent of cancer initiation",
        "Dynamics between cancer cell subpopulations reveals a model coordinating with both hierarchical and stochastic concepts",
        "Targeting the perpetrator: Breast cancer stem cell therapeutics",
        "The origin of cancer stem cells",
        "Hepatocellular carcinoma stem cells: Origins and roles in hepatocarcinogenesis and disease progression",
        "Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment",
        "Mechanisms of chemoresistance in cancer stem cells",
        "Targeting lung cancer stem cells: Research and clinical Impacts",
        "Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies",
        "Beta-catenin signaling and cancer",
        "Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)",
        "Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: Clinical update",
        "C-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells",
        "An overview of MYC and its interactome",
        "MYC degradation",
        "MiR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth",
        "C-Myc modulates microRNA processing via the transcriptional regulation of Drosha",
        "Making Myc",
        "Wnt breakers in colon cancer",
        "Functional interaction of protein kinase CK2 and c-Myc in lymphomagenesis",
        "Protein kinase CK2: Structure, regulation and role in cellular decisions of life and death",
        "Joining the cell survival squad: An emerging role for protein kinase CK2",
        "Casein kinase II inhibits the DNAbinding activity of Max homodimers but not Myc/Max heterodimers",
        "Targeting of the transcription factor max during apoptosis: Phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1",
        "The life cycle of c-Myc: From synthesis to degradation",
        "C-Myc phosphorylation is required for cellular response to oxidative stress",
        "C-Myc transactivation domainassociated Kinases: Questionable role for Map kinases in c-Myc phosphorylation",
        "Hierarchical phosphorylation at Nterminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis",
        "Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability",
        "Ras enhances Myc protein stability",
        "Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase",
        "MYC degradation: Deubiquitinating enzymes enter the dance",
        "Knockdown of c-Myc activates Fas-mediated apoptosis and sensitizes A549 cells to radiation",
        "Artemisitene suppresses tumorigenesis by inducing DNA damage",
        "Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Second Century Fund",
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}